Seed/Nut/Grain Variants · Seed Oils
Baobab Seed Oil (Adansonia digitata) (Adansonia digitata)
Preliminary EvidenceCompound
Hermetica Superfood Encyclopedia
Baobab seed oil, cold-pressed from the seeds of Adansonia digitata, is rich in linoleic acid (omega-6), oleic acid (omega-9), and palmitic acid, which collectively support the skin's lipid barrier and reduce transepidermal water loss. Its fatty acid profile drives both its moisturizing efficacy and its preliminary cholesterol-modulating and cytotoxic properties observed in early research.
Baobab Seed Oil is derived from the seeds of Adansonia digitata L., the African baobab tree native to semiarid regions of Africa such as Tanzania. The oil is extracted via mechanical pressing or supercritical CO₂ extraction, yielding a vegetable oil rich in fatty acids including linoleic, palmitic, and oleic acids.
No human clinical trials specifically on baobab seed oil have been conducted. One ongoing RCT (PMID: 40802664) examines baobab fruit powder in 50 obese adults for gut permeability and cardiometabolic effects, but this does not include seed oil. Available evidence focuses primarily on baobab fruit pulp in animal models, with human trials on fruit extracts showing mixed effects on glucose response.
No clinically studied dosage ranges are available for baobab seed oil as human trials are lacking. The FDA has condemned consumption of crude baobab seed oil due to carcinogenic cyclopropenoid fatty acids, though these can be reduced below 0.4% by heating at 250°C for 15 minutes. Consult a healthcare provider before starting any new supplement.
Baobab Seed Oil (Adansonia digitata) is a fixed vegetable oil with a distinctive fatty acid composition dominated by unsaturated fats. Primary fatty acids include oleic acid (omega-9, approximately 33–36%), linoleic acid (omega-6, approximately 26–31%), palmitic acid (saturated, approximately 20–25%), and stearic acid (saturated, approximately 3–8%), with minor amounts of arachidic acid (<1%) and behenic acid (<1%). The oil is notably rich in tocopherols (vitamin E complex), with total tocopherol content estimated at 300–500 mg/kg, predominantly as alpha-tocopherol and gamma-tocopherol, which contribute to both antioxidant activity and oxidative stability. Phytosterols are present at approximately 1,000–2,500 mg/kg, including beta-sitosterol (dominant), campesterol, and stigmasterol, which are implicated in the cholesterol-modulating properties attributed to the oil. The oil contains cyclopropene fatty acids (malvalic and sterculic acids) at trace levels, a characteristic shared with other Malvaceae-adjacent species, though concentrations are generally considered low in cold-pressed preparations. Polyphenolic compounds are present in minor quantities, contributing to the mild antioxidant capacity of unrefined oil. The oil is largely free of protein, carbohydrates, and dietary fiber, as these are removed during expression. Bioavailability of fatty acids is high via topical absorption due to the oil's relatively small molecular weight and lipid compatibility with the stratum corneum; systemic bioavailability upon oral ingestion follows standard lipid digestion pathways via chylomicron transport. No significant mineral content is retained in the expressed oil. Data on carotenoid content is limited but trace beta-carotene has been reported in unrefined cold-pressed variants.
Baobab seed oil's high linoleic acid content (approximately 26–36%) replenishes ceramide precursors in the stratum corneum, restoring lamellar body secretion and reducing transepidermal water loss by reinforcing the epidermal permeability barrier. Oleic acid (approximately 36–41%) facilitates percutaneous penetration by disrupting tight lipid packing between corneocytes, enhancing delivery of bioactive compounds. Preliminary in vitro data suggest that specific fatty acid fractions may induce apoptosis in MCF-7 breast cancer cells, potentially via mitochondrial pathway activation and downregulation of anti-apoptotic Bcl-2 proteins, though the precise molecular targets remain uncharacterized.
Clinical evidence for baobab seed oil is limited and predominantly derived from in vitro assays and traditional ethnobotanical use rather than randomized controlled trials. Fatty acid composition analyses confirm a high proportion of linoleic acid, palmitic acid, and oleic acid, lending plausibility to its topical moisturizing claims, but no large-scale human trials have quantified outcomes such as TEWL reduction or SCORAD improvement against a placebo. One in vitro study reported cytotoxic activity against human breast cancer cell lines attributable to the oil's fatty acid fraction, though no clinical translation has been established. A small number of animal and cell-culture studies suggest modest lipid-lowering effects correlated with oleic acid content, but human pharmacokinetic and efficacy data are currently absent, meaning all systemic health claims must be considered preliminary.
Baobab seed oil applied topically is generally regarded as non-irritant and non-sensitizing based on traditional use records across sub-Saharan African populations, with no significant adverse reactions reported in available literature. No well-documented drug interactions have been identified for topical application, though oral ingestion of concentrated oil could theoretically potentiate the effects of anticoagulants such as warfarin due to its polyunsaturated fatty acid content affecting platelet aggregation. Individuals with tree nut or seed oil allergies should perform a patch test prior to widespread topical use, as cross-reactivity cannot be excluded. Safety data for oral supplementation during pregnancy and lactation are insufficient to make a recommendation, and use in these populations should be deferred until controlled studies are available.
